Beez, Belgium

Johan Wouters

This inventor holds 1 USPTO granted patent. Top assignees: Facultés Universitaires Notre-Dame De La Paix, Université Libre De Bruxelles. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johan Wouters. Retrieved from https://idiyas.com/inventor/johan-wouters-383q8w4k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Johan Wouters

Introduction

Johan Wouters is a notable inventor based in Beez, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Wouters holds a patent for "Beta carboline derivatives useful in the treatment of proliferative disorders." This invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) that are useful in treating proliferative disorders, including cancer. The patent also details intermediates used in their preparation, processes for preparing the compounds, and their various uses.

Career Highlights

Throughout his career, Johan Wouters has worked with esteemed institutions such as Facultés Universitaires Notre-Dame de la Paix and Université Libre Bruxelles. His work in these organizations has contributed to advancements in research and development in the field of medicinal chemistry.

Collaborations

Wouters has collaborated with notable colleagues, including Raphael Frederick and Bernard Masereel. These partnerships have fostered innovation and have been instrumental in the progress of his research endeavors.

Conclusion

Johan Wouters is a distinguished inventor whose work in developing beta-carboline derivatives showcases his commitment to advancing medical treatments. His contributions to the field are significant and continue to impact the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…